13 completed, 7 not yet recruiting, 4 unknown, 3 recruiting. 10 Phase 3, 6 Phase 2, 3 Phase 4, 1 Not applicable, 1 Phase 1.
Follow Non-Radiographic Axial Spondyloarthritis: new trials by email Literature Review of Non-Radiographic Axial Spondyloarthritis trials Research Report on Non-Radiographic Axial Spondyloarthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety of Subcutaneous Secukinumab for Treatment in Adult Indian Participants With Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS), and Non-Radiographic Axial Spondyloarthritis (nr-axSpA) Axial Spondyloarthritis, Ankylosing Spondylitis | Not yet recruiting | Novartis Pharmaceuticals | 60 | 2026-09-30 | 2026-07-30 | |
| Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy vilamakitug, placebo - Axial Spondyloarthritis, Ankylosing Spondylitis | Phase 2 | Not yet recruiting | XBiotech, Inc. | 150 | 2026-09-01 | 2026-05-14 |
| The REFLECT Study- Flares in axSpA Axial Spondyloarthritis (AxSpA), Axial Spondyloarthritis, Non-Radiographic | Active not recruiting | Royal United Hospitals Bath NHS Foundation Trust | 40 | 2026-06-01 | 2026-07-07 | |
| Effectiveness and Safety of Acemetacin in Active Axial Spondyloarthritis: A Real-world Study Acemetacin - Axial Spondyloarthritis, Axial Spondyloarthritis, Non-Radiographic | Phase 4 | Not yet recruiting | Chinese PLA General Hospital | 150 | 2026-04-01 | 2026-05-12 |
| A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) 608, Placebo - Axial Spondyloarthritis, Non-Radiographic | Phase 3 | Not yet recruiting | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 380 | 2026-03-09 | 2026-01-16 |
| Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial Spondyloarthritis Xeligekimab injection - Nr-axial Spondyloarthritis, Non-Radiographical Axial Spondyloarthritis | Phase 2 / Phase 3 | Not yet recruiting | Lingli Dong | 40 | 2026-01-31 | 2026-01-14 |
| A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases. Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA) | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 10000 | 2025-01-30 | 2025-01-09 | |
| Chinese Spondyloarthritis Inception Cohort (CESPIC) Celecoxib - Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA), Non-radiographic Axial Spondyloarthritis (Nr-axSpA) | Not yet recruiting | Southwest Hospital, China | 1000 | 2024-09-01 | 2024-04-17 | |
| A LONGITUDINAL OBSERVATIONAL STUDY to EVALUATE the EFFICACY of MOVEMENT and IMPLEMENT CONCRETE MOVEMENT RECOMMENDATIONS with the HELP of MOBILITY TRACKING with SMARTWATCHES in SUBJECTS with AXIAL SPONDYLOARTHRITIS Smartwatch - Axial Spondyloarthritis, Axial Spondyloarthritis (AxSpA) | Recruiting | University of Bonn | 50 | 2024-04-01 | 2025-02-18 | |
| A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) 608, Placebo - Axial Spondyloarthritis | Phase 2 | Recruiting | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 180 | 2024-03-22 | 2025-03-11 |
| Osteosarcopenia in Axial Spondyloarthritis Axial Spondyloarthritis, Ankylosing Spondylitis | Unknown | Ankara University | 97 | 2023-09-01 | 2024-08-29 | |
| A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission Secukinumab, Placebo - Non-radiographic Axial Spondyloarthritis | Phase 4 | Active not recruiting | Novartis Pharmaceuticals | 240 | 2023-03-28 | 2026-10-14 |
| A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease Companion blood samples with procedure - Autoimmune Diseases, Ulcerative Colitis | Completed | TScan Therapeutics, Inc. | 238 | 2023-01-03 | 2026-09-15 | |
| A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis SHR0302, SHR0302 placebo - Non-radiographic Axial Spondyloarthritis | Phase 3 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 300 | 2022-08-16 | 2022-09-02 |
| A Clinical Study With Adalimumab Biosimilar Humira® (adalimumab) AC Pen [Reference Product], Adalimumab Richmond [Test Product] - Pharmacokinetics, Safety Issues | Phase 1 | Completed | Laboratorios Richmond S.A.C.I.F. | 150 | 2022-08-01 | 2024-03-04 |
| Yuflyma® (Adalimumab), Patient Experience After Switching Adalimumab - Rheumatoid Arthritis, Ankylosing Spondylarthritis | Unknown | Celltrion HealthCare France | 300 | 2022-06-03 | 2022-06-22 | |
| 2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis secukinumab - Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis | Completed | Novartis Pharmaceuticals | 127 | 2022-03-25 | 2025-12-01 | |
| Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active Nr-axSpA JS005, Placebo - Non-radiographic Axial Spondyloarthritis | Phase 2 | Terminated | Shanghai Junshi Bioscience Co., Ltd. | 23 | 2021-12-31 | 2026-07-21 |
| Efficacy and Safety Study of Secukinumab in Chinese Participants With Non-radiographic Axial Spondyloarthritis Secukinumab, Placebo - Non-radiographic Axial Spondyloarthritis | Phase 3 | Completed | Novartis Pharmaceuticals | 137 | 2021-07-21 | 2026-04-09 |
| Evaluation of Spine Posture, Trunk Position Sense and Gait in Axial Spondyloarthritis Patients Gait parameters, Spine posture, Trunk position sense - Non-radiographic Axial Spondyloarthritis, Ankylosing Spondylitis | Not applicable | Unknown | Necmettin Erbakan University | 75 | 2021-07-15 | 2021-09-20 |
Showing 20 of 32. Sign in to see all of them.
Spondylitis, Ankylosing (21) · Axial Spondyloarthritis (16) · Colitis, Ulcerative (6) · Arthritis, Psoriatic (5) · Crohn Disease (5) · Arthritis, Rheumatoid (3) · Arthritis, Juvenile (2) · Sacroiliitis (2) · Uveitis, Anterior (2) · Arthritis (1) · Arthritis, Reactive (1) · Autoimmune Diseases (1) · Birdshot Chorioretinopathy (1) · Celiac Disease (1)
Ankylosis (32) · Bone Diseases (32) · Joint Diseases (32) · Musculoskeletal Diseases (32) · Spondylitis (32) · Arthritis (31) · Spinal Diseases (31) · Spondylarthritis (31) · Spondylarthropathies (31) · Axial Spondyloarthritis (16) · Colitis (6) · Colonic Diseases (6) · Digestive System Diseases (6) · Gastroenteritis (6) · Gastrointestinal Diseases (6)
secukinumab (6) · Adalimumab (2) · bimekizumab (2) · Celecoxib (1) · Certolizumab Pegol (1) · Etanercept (1) · Standard of Care (1) · acemetacin (1) · brodalumab (1) · ivarmacitinib (1)
Novartis Pharmaceuticals (7) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (2) · UCB Biopharma SRL (2) · AbbVie (1) · Amgen (1) · Ankara University (1) · Celltrion HealthCare France (1) · Charite University, Berlin, Germany (1) · Chinese PLA General Hospital (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Laboratorios Richmond S.A.C.I.F. (1) · Lingli Dong (1) · Necmettin Erbakan University (1) · Pfizer (1) · Royal United Hospitals Bath NHS Foundation Trust (1)
China (10) · Germany (8) · Poland (8) · United States (8) · Belgium (7) · Czechia (7) · France (6) · Hungary (6) · Spain (6) · Turkey (Türkiye) (6) · Bulgaria (5) · United Kingdom (5) · Italy (4) · Colombia (3) · Greece (3)
Qinghong Zhou, BS (2) · Xiaofeng Zeng, MD (2) · Denis Poddubnyy, Prof. Dr. (1) · Ethel C. Feleder, MD (1) · Fabian Proft, MD (1) · Joachim Sieper, Prof. Dr. (1) · Martin Rudwaleit, Prof. Dr. (1) · Raj Sengupta, Professor (1)
PMID 19248087, PMID 20498207, PMID 21622969, PMID 21885496, PMID 40194794, PMID 41125403, PMID 41314667, PMID 41807031, PMID 42128532, PMID 42297437, PMID 42386286, PMID 15051621, PMID 15365877, PMID 17728332, PMID 19060001, PMID 21647573, PMID 22018588, PMID 22186710, PMID 22459541, PMID 22569245, PMID 23625981, PMID 23956246, PMID 24845387, PMID 25417763, PMID 26017497, PMID 27125522, PMID 27162010, PMID 27188328, PMID 27401188, PMID 28405472, PMID 29065931, PMID 29373733, PMID 30312372, PMID 30513782, PMID 30809016, PMID 30848558, PMID 31126334, PMID 31362994, PMID 32941253, PMID 32996809, PMID 32998926, PMID 33053193, PMID 34707696, PMID 34715908, PMID 35296532, PMID 35733363, PMID 36379575, PMID 36649967, PMID 37162744, PMID 37793792
2015 (2), 2017 (2), 2023 (2), 2014 (1), 2018 (1), 2019 (1)